Virtual COVID-19: Recap
Virtual COVID-19 2020 Conference: Rapid Audio Recap

Released: August 19, 2020

Expiration: August 18, 2021

Renslow Sherer
Renslow Sherer, MD

Activity

Progress
1
Course Completed

In this episode, Dr. Sherer discusses results from key studies reported at the International AIDS Society’s 2020 Virtual COVID-19 Conference, including studies evaluating characteristics and predictors of COVID-19 mortality, factors associated with remdesivir clinical outcomes, the effect of hydroxychloroquine coadministration on remdesivir safety and efficacy, the effect of race/ethnicity on clinical outcomes with remdesivir, and sofosbuvir/daclatasvir plus lopinavir/ritonavir for the treatment of severe COVID-19. 

Content based on a CME program supported by an independent educational grant from Gilead Sciences.

Link to full program: https://www.clinicaloptions.com/infectious-disease/conference-coverage/covid19-2020